Sign in
4

Changes in Ownership

Caris Life Sciences, Inc. Filed Acc 0002071953-25-000008

President bought 400 shares at $23.85 ($9,540)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Spetzler David Baxley President 2025-11-07 Purchase +400 $23.85 $9,540 460,777 D: show line 1 in the form
Open-market purchases · 400 sh · avg $23.85 · $9,540
Loading xslF345X05/wk-form4_1762780290.xml…